Vaxess develops the MIMIX microarray patch platform: dissolvable, shelf‑stable skin patches and applicator for controlled, sustained delivery of vaccines and therapeutics, including mRNA, without refrigeration.
vaxess.comPart of: Boston tech scene from Fundable